Genxone is a company headquartered in Poland.
Genxone provides next-generation sequencing (NGS) services, molecular diagnostics, and the evaluation of medical devices' efficacy using technologies such as nanopore sequencing and Real Time PCR.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.